Showing results (91-100 of 302) with videos related to

Sort By:
Pageof 31
American Journal of Clinical Oncology|March 26, 2015
Efficacy of oxaliplatin-based chemotherapy + bevacizumab as first-line treatment for advanced colorectal cancer: a systematic review and pooled analysis of published trialsFausto Petrelli, Andrea Coinu, Mara Ghilardi, et al.
Expert Review of Anticancer Therapy|September 16, 2011
Optimal use of recombinant granulocyte colony-stimulating factor with chemotherapy for solid tumorsMarco Danova, Sandro Barni, Lucia Del Mastro, et al.
Breast Cancer Research and Treatment|November 3, 2016
Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trialsFausto Petrelli, Sandro Barni, Giacomo Bregni, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 3, 2017
Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trialsFausto Petrelli, Gianluca Tomasello, Michele Ghidini, et al.
Breast Cancer Research and Treatment|July 18, 2013
Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trialsFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
Recenti Progressi in Medicina|April 9, 2008
[Cost-effectiveness of oral ibandronate, i.v. zoledronic acid and i.v. generic pamidronate in the management of metastatic bone disease in breast cancer patients: two parallel studies]Chiara Schivazappa, Patrizia Berto, Editta Baldini, et al.
Critical Reviews in Oncology/Hematology|January 25, 2021
Serum tumour markers in germ cell tumours: From diagnosis to curePaolo Pedrazzoli, Giovanni Rosti, Eleonora Soresini, et al.
Seminars in Oncology|May 12, 2019
Primary mediastinal germ cell tumorsGiovanni Rosti, Simona Secondino, Andrea Necchi, et al.
Seminars in Hematology|October 27, 2007
High-dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adultsPaolo Pedrazzoli, Giovanni Rosti, Simona Secondino, et al.
Tumori|February 11, 2012
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic reviewMario Airoldi, Dino Amadori, Sandro Barni, et al.
Pageof 31